SecBot SecBot
144 ·Filed Nov 5, 2026

CDNA

CareDx, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed11d 7h ago SEC0001950047-26-010736
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

Monitor for actual sales on Form 4 filings to confirm execution. The multi-month window and option-exercise sourcing suggest a planned liquidity event rather than a reactive sale.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$78.56
T+0 close · Nov 5, 2026 · via day close
Latest settled
−0.87%
T+5 · $77.88
Vs SPY
−3.46%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $78.56entry
  2. T+1 · 8d ago +7.46%α +5.09% · $84.42
  3. T+5 · 4d ago −0.87%α −3.46% · $77.88
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Keith Kennedy filed a Form 144 notice of intent to sell up to 79,243 shares of CareDx common stock, with an approximate market value of $6.8 million based on the filing. The shares were acquired through option exercises, ESPP, and equity grants, and the sale is planned for execution over the next three months.

Key Facts

  • Director Keith Kennedy filed a Form 144 to sell up to 79,243 shares.
  • The approximate market value of the proposed sale is $6.8 million.
  • Shares were acquired via stock option exercises, employee stock purchase plan, restricted stock units, and performance stock units.
  • The sale is planned to occur over the next three months.
  • The filing notes that securities to be sold will be received upon exercise of stock options over the next three months.

Financial Impact

Proposed sale of 79,243 shares valued at approximately $6.8 million.

dilution

Risk Factors

  • Insider sale may signal reduced conviction if executed aggressively.
  • Form 144 is an intent to sell; actual sales may not occur or may differ in size.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010736
Document: 0001950047-26-010736-index.html0001950047-26-010736
Document: 0001950047-26-010736.txt0001950047-26-010736

Track record

16 reports on CDNA

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +28.28% at T+60 after the Apr 16, 2026 report. 3 of 5 went positive at some point.

Filters
  1. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $77.88 Now $73.72 −5.34% settles Feb 11
  2. Nov 12, 20264d ago 144 Neutral 2/10 Entry $77.88 Now $73.72 −5.34% settles Feb 11
  3. Nov 10, 20266d ago 144 Neutral 2/10 Entry $81.17 Now $73.72 −9.18% settles Feb 9
  4. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $80.77 Now $73.72 −8.73% settles Feb 8
  5. Nov 5, 202611d ago 144 Neutral 3/10 Viewing Entry $78.56 Now $73.72 −6.16% settles Feb 4
  6. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $87.41 Now $73.72 −15.66% settles Jan 28
  7. Oct 29, 202618d ago Institutional Cluster Bearish 4/10 Entry $71.52 Now $73.72 −3.08% settles Jan 27
  8. Aug 6, 202614w ago Insider Cluster Neutral 3/10 Entry $46.69 to $86.54 Now $73.72 +57.89% ▲ +85.34% +87.47% vs SPY
  9. Aug 4, 202614w ago 144 Neutral 2/10 Entry $45.50 Now $73.72 +62.02% No price data
  10. Jul 17, 202617w ago Insider Cluster Neutral 4/10 Entry $39.73 Now $73.72 +85.55% No price data
Showing 10 of 16

US Market Status

Market Closed · Opens Wed (9h 53m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026